drugset / Trial / NCT04080505

Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?

NCT04080505

Phase 3 Terminated 29 enrolled Columbia University
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this research is to find out if SSKI (Potassium Iodide) reduces vascularity (the number and concentration of blood vessels) and improves how well patients do after surgery for removal of their whole thyroid gland in Graves' disease (an autoimmune disease that is a common cause of hyperthyroidism).

Timeline

Start
2015-02-10
Primary completion
2023-03-03
Completion
2023-03-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator potassium iodide Unknown Oral

Indications